We are live on ! Find out more
BA

BlackRock Advisors Portfolio holdings

AUM $98.8B
1-Year Est. Return 15.8%
This Fund
S&P 500
This Quarter Est. Return
+1.95%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
10 Year Est. Return
AUM
$97.6B
AUM Growth
-$1.7B
Cap. Flow
-$3.16B
Cap. Flow %
-3.24%
Top 10 Hldgs %
14.39%
Holding
3,772
New
78
Increased
2,174
Reduced
812
Closed
154

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$382M
2
HSP
HOSPIRA INC
HSP
+$235M
3
MRK icon
Merck
MRK
+$227M
4
AGN
Allergan Inc
AGN
+$199M
5
AXP icon
American Express
AXP
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 19.47%
2 Financials 16.8%
3 Industrials 9.81%
4 Technology 8.84%
5 Energy 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASBI
3326
DELISTED
AMERIANA BANCORP
ASBI
$32K ﹤0.01%
1,956
ISH
3327
DELISTED
INTL SHIPHOLDING CORP
ISH
$32K ﹤0.01%
2,641
+332
+14% +$4.87K
SLI
3328
DELISTED
S L INDUSTRIES INC (DELAWARE)
SLI
$32K ﹤0.01%
750
-38
-5% -$1.56K
ACNT icon
3329
Ascent Industries
ACNT
$138M
$31K ﹤0.01%
2,147
GALT icon
3330
Galectin Therapeutics
GALT
$223M
$31K ﹤0.01%
9,174
+1,631
+22% +$5.83K
OSBC icon
3331
Old Second Bancorp
OSBC
$1.27B
$31K ﹤0.01%
5,393
RCKY icon
3332
Rocky Brands
RCKY
$313M
$31K ﹤0.01%
1,434
+128
+10% +$2.24K
TRUP icon
3333
Trupanion
TRUP
$1.08B
$31K ﹤0.01%
3,837
+740
+24% +$5.62K
VERU icon
3334
Veru
VERU
$36.6M
$31K ﹤0.01%
1,103
+295
+37% +$10.3K
SEEL
3335
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
GNMX
3336
DELISTED
Aevi Genomic Medicine Inc
GNMX
$31K ﹤0.01%
3,825
HGT
3337
DELISTED
Hugoton Royalty Trust
HGT
$31K ﹤0.01%
+5,226
New +$38.8K
ZU
3338
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
$31K ﹤0.01%
2,373
DWSN icon
3339
Dawson Geophysical
DWSN
$149M
$30K ﹤0.01%
7,328
+5,753
+365% +$31.1K
MLP icon
3340
Maui Land & Pineapple Co
MLP
$343M
$30K ﹤0.01%
5,106
UEC icon
3341
Uranium Energy
UEC
$4.9B
$30K ﹤0.01%
19,733
PMD
3342
DELISTED
Psychemedics Corporation
PMD
$30K ﹤0.01%
1,801
UCP
3343
DELISTED
UCP, Inc.
UCP
$30K ﹤0.01%
3,432
+476
+16% +$4.44K
GEG icon
3344
Great Elm Group
GEG
$67.7M
$29K ﹤0.01%
4,296
LSTA icon
3345
Lisata Therapeutics
LSTA
$13.1M
$29K ﹤0.01%
76
+9
+13% +$4.88K
SFBS
3346
ServisFirst Bancshares
SFBS
$4.82B
$29K ﹤0.01%
1,778
+314
+21% +$4.95K
VANI icon
3347
Vivani Medical
VANI
$112M
$29K ﹤0.01%
+93
New +$25.9K
WNEB icon
3348
Western New England Bancorp
WNEB
$290M
$29K ﹤0.01%
3,799
QUMU
3349
DELISTED
Qumu Corp.
QUMU
$29K ﹤0.01%
2,149
LUB
3350
DELISTED
Luby's Inc.
LUB
$29K ﹤0.01%
5,639

Similar funds

BlackRock Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, BlackRock Advisors held 3,772 positions worth $97.6B, down 1.7% from $99.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

BlackRock Advisors withdrew a net $3.16B in Q1 2015, closing 154 positions and reducing 812 holdings. Its most notable exit was Allergan Inc, an estimated $199M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.

Against the trend, BlackRock Advisors opened a new position in Mobileye N.V. worth $252M.

  • BlackRock Advisors's largest Q1 2015 buy was Mobileye N.V.: 6,000,666 shares worth $252M.
  • BlackRock Advisors added most to UnitedHealth in Q1 2015, an estimated $461M increase.
  • BlackRock Advisors's biggest Q1 2015 reduction was Chevron, cutting an estimated $382M.
  • BlackRock Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $199M.
  • BlackRock Advisors's ten largest holdings make up 14% of its $97.6B portfolio in Q1 2015.
  • BlackRock Advisors opened 78 new positions and closed 154 in Q1 2015.
  • BlackRock Advisors's portfolio value fell 1.7% quarter-over-quarter to $97.6B.

Based on BlackRock Advisors's 13F filing for Q1 2015, filed 13 May 2015.